Results 21 to 30 of about 3,484,780 (294)

The international, prospective Glanzmann Thrombasthenia Registry: treatment modalities and outcomes of non-surgical bleeding episodes in patients with Glanzmann thrombasthenia

Haematologica, 2015
Standard treatment for Glanzmann thrombasthenia is platelet transfusion. Recombinant activated factor VII has been shown to be successful in patients with Glanzmann thrombasthenia with platelet antibodies or who are refractory to platelet transfusions ...
Giovanni Di Minno, Rainer B Zotz, Roseline d’Oiron, Niels Bindslev, Matteo Nicola Dario Di Minno, Man-Chiu Poon   +5 more
doaj   +1 more source

Acquired factor V inhibitors in a polytraumatized patient [PDF]

Vojnosanitetski Pregled, 2005
Background. Factor V (FV) inhibitors are a rare disorder reported for the first time about fifty years ago, mostly with the unknown cause. The appearance of FV inhibitors is usually preceded by surgery, infections, administration of antibiotics or ...
Tukić Ljiljana, Stamatović Dragana, Tarabar Olivera, Elez Marija, Zorić Miodrag, Mandić-Radić Slavka   +5 more
doaj   +1 more source

The International Prospective Glanzmann Thrombasthenia Registry: Pediatric Treatment and Outcomes

TH Open, 2019
Background Standard treatment for Glanzmann thrombasthenia (GT), a severe inherited bleeding disorder, is platelet transfusion. Recombinant activated factor VII (rFVIIa) is reported to be effective in GT with platelet antibodies and/or refractoriness to ...
Rainer B. Zotz, Man-Chiu Poon, Giovanni Di Minno, Roseline D'Oiron   +3 more
doaj   +1 more source

Peculiarities of blood coagulation disorders in patients with COVID-19

Терапевтический архив, 2021
Aim. To study the relationship of hemostatic disorders with inflammation and estimate their role in the course and outcomes of COVID-19. Materials and methods. We examined 215 consecutive patients with moderate and severe forms of acute COVID-19.
Natalia G. Evtugina, Svetlana S. Sannikova, Alina D. Peshkova, Svetlana I. Safiullina, Izabella A. Andrianova, Gulzada R. Tarasova, Alina I. Khabirova, Aleksandr G. Rumyantsev, Fazoil I. Ataullakhanov, Rustem I. Litvinov   +9 more
doaj   +1 more source

Time course of clotting and fibrinolytic markers in acute upper gastrointestinal bleeding : relation to diagnosis and blood transfusion treatment

, 1993
One hundred consecutive patients with acute upper gastrointestinal bleeding were investigated. Blood coagulation and fibrinolytic activity were monitored by levels of plasma thrombin-antithrombin III (TAT) complex and plasmin-alpha 2-antiplasmin (PAP ...
Svensson, J O,, Henriksson, Anders E.,, Nilsson, T K,   +2 more
core   +8 more sources

MODERN ASPECTS OF COAGULOPATHY DEVELOPMENT IN PATIENTS WITH COVID-19 INFECTION: LITERATURE REVIEW

Проблеми екології та медицини, 2021
This review summarizes current knowledge about coagulation disorders associated with COVID-19 infection. Despite a significant amount of research, it is currently unclear whether COVID-19 is the direct cause of coagulopathic disorders or they occur as ...
M.O. Dudchenko, S.М. Zaiets, R.A. Prykhidko   +2 more
doaj   +1 more source

What role do coagulation disorders play in the pathogenesis of leptospirosis? [PDF]

, 2007
Leptospirosis is a zoonosis of worldwide distribution, spread by the urine of infected animals. It is a major public health problem, especially in developing countries, where circumstances for transmission are most favourable. The clinical picture varies
de Kruif, MD, ten Cate, H, Hartskeerl, Rudy A., Brandjes, DPM, Sakundarno, Mateus, Gasem, M. Hussein, Mairuhu, ATA, Wagenaar, Jiri F.P., van Gorp, Eric C. M., Goris, Marga G.A.   +9 more
core   +1 more source

Requirements for receptor engagement during infection by adenovirus complexed with blood coagulation factor X [PDF]

, 2010
Human adenoviruses from multiple species bind to coagulation factor X (FX), yet the importance of this interaction in adenovirus dissemination is unknown.
Angela C Bradshaw, Duffy, Margaret R., Andrew H. Baker, Lynda Coughlan, Coughlan Lynda, Baker Andrew H., van Rooijen, Nico, van Rooijen, N., Nicklin, Stuart A., Margaret R Duffy, Parker, A.L., Kahari, V.M., Alan L Parker, Kähäri Veli-Matti, Stuart A Nicklin, Nico van Rooijen, Andrew H Baker, Coughlan, L., Nicklin Stuart A., Coughlan, Lynda, Kahari, Veli-Matti, Duffy, M.R., Parker Alan L., Bradshaw Angela C., Parker, Alan L., Duffy Margaret R., Bradshaw, Angela C., Bradshaw, A.C., Rooijen, N. van, Veli-Matti Kähäri, Angela C. Bradshaw, Alan L. Parker, Margaret R. Duffy, Stuart A. Nicklin, Baker, Andrew H., Baker, A.H., Nicklin, S.A., van Rooijen Nico   +37 more
core   +3 more sources

Combined oral contraceptives containing estradiol valerate vs ethinylestradiol on coagulation: A randomized clinical trial

Acta Obstetricia et Gynecologica Scandinavica, 2022
Introduction Contraceptives containing ethinylestradiol (EE) induce changes in the coagulation system and are associated with a risk of venous thromboembolism.
Annina H. Haverinen, Kaisu M. Luiro, Timea Szanto, Marika H. Kangasniemi, Leena Hiltunen, Susanna Sainio, Terhi T. Piltonen, Riitta Lassila, Juha S. Tapanainen, Oskari Heikinheimo   +9 more
doaj   +1 more source

Validation of anaemia, haemorrhage and blood disorder reporting in hospital data in New South Wales, Australia

BMC Research Notes, 2021
Objective Hospital data are a useful resource for studying pregnancy complications, including bleeding-related conditions, however, the reliability of these data is unclear.
Heather J. Baldwin, Tanya A. Nippita, Siranda Torvaldsen, Therese M. McGee, Kristen Rickard, Jillian A. Patterson   +5 more
doaj   +1 more source